Advanced Filters
noise

Altindag, Turkey Clinical Trials

A listing of Altindag, Turkey clinical trials actively recruiting patients volunteers.

Found 292 clinical trials

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

The purpose of this study is to provide continued treatment with alectinib or crizotinib as applicable to participants with ALK- or RET positive cancer who were previously enrolled in any Roche-sponsored alectinib study and who are deriving continued clinical benefit from alectinib or crizotinib in the parent trial at the …

- 100 years of age Both Phase 3
E Ekin Taçalan

Inspiratory Muscle Training on Balance, Falls and Diaphragm Thickness in the Elderly

Decreases in body muscle mass, function and strength occur with ageing and this condition is called "sarcopenia". It is known that sarcopenic elderly people fall more than non-sarcopenic elderly people, their balance is negatively affected, their diaphragm thickness decreases and their quality of life may decrease due to their lower …

65 - 100 years of age Both Phase N/A
N Nuriye Ebru Ergenekon, Prof. Dr

Alliance for Family Integrated Care Implementation in Neonatal Intensive Care Units

International, multi-centre, pluri-cultural, stepped wedge cluster controlled trial, to demonstrate superiority of site tailored 'Family integrated care model'(FICare), that promotes the active participation of the parents as primary caregivers of their infants in neonatal intensive care units (NICU), versus standard NICU care delivery with regards to short-term health outcomes in …

- 1 years of age Both Phase N/A
Ö Özlem Ülger, proffesor

The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis

The term non-alcoholic fatty liver disease (NAFLD) is used to describe a range of chronic liver diseases that range from steatosis to steatohepatitis, advanced fibrosis, cirrhosis, or excessive alcohol consumption or other causes of steatosis. In this spectrum, Non-Alcoholic Steatohepatitis (NASH), which defines liver damage accompanied by steatosis and inflammation …

18 - 65 years of age Both Phase N/A
U US GSK Clinical Trials Call Center

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

The aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (including mild cognitive impairment [MCI] and mild dementia due to AD) of 2 dose levels of GSK4527226 compared to placebo.

50 - 85 years of age Both Phase 2

A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria

The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein consumption.

- 100 years of age Both Phase 3
M M Overbeek

Cough Reduction in IPF With Nalbuphine ER

This is a multi-center randomized, double-blind, placebo-controlled, parallel, 4-arm study of nalbuphine ER (NAL ER). After meeting eligibility during the Screening Period, subjects will be randomized (1:1:1:1) to one of four treatment arms. Arm 1: Placebo Arm 2: 27 mg nalbuphine ER Arm 3: 54 mg nalbuphine ER Arm 4: …

18 - 100 years of age Both Phase 2

A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)

The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of V116 compared to PPSV23 in children 2 through 17 years of age. Researchers want to learn if V116 is as good as, or is better than the PPSV23 vaccine in terms of the antibody immune response. …

2 - 17 years of age Both Phase 3
A Ayşegül Özel Erdem, assistant doctor

How Do We Ultrasound-Guided Popliteal Approach Sciatic Nerve Block?

The aim of this prospective, randomized, observer-blind study to compare subparaneural approach injection with interneural approach injection in popliteal sciatic nerve blocks.

18 - 100 years of age Both Phase N/A

A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

The purpose of this study is to evaluate the efficacy and safety of nemtabrutinib compared to investigator's choice of fludarabine plus cyclophosphamide plus rituximab (FCR) or bendamustine plus rituximab (BR) in participants with previously untreated CLL/SLL without 17p deletion and/or tumor protein (TP) 53 mutation. The primary hypothesis is that …

18 - 100 years of age Both Phase 3

Rewrite in simple language using AI